Specialty Pharma Canyon Takes Leech-Inspired Anticoagulant Approved In 2003 To Market

Iprivask, "the first direct thrombin inhibitor approved in the U.S.," was found superior to both heparin and Lovenox but fell through the cracks during pharma M&A activity, Canyon exec says.